T/R potency <5% [Regulatives / Guidelines]

posted by Achievwin – US, 2022-09-07 20:22 (1392 d 04:55 ago) – Posting: # 23275
Views: 8,457

Colleagues:

Somewhere in the Bioequivalence guidance I remembered that when designing the studies we try to keep T/R potency +/-5%. Can someone point out where this kind of condition existed, (latest guidance has no mention of this)

Thanks in advance for your guidance,

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
350 visitors (0 registered, 350 guests [including 57 identified bots]).
Forum time: 01:18 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5